BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8417825)

  • 1. Antitumor effect of interleukin 1 alpha in combination with hyperthermia.
    Song CW; Lin JC; Lyons JC
    Cancer Res; 1993 Jan; 53(2):324-8. PubMed ID: 8417825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of interleukin 1 alpha mediated antitumor effects by ketoconazole.
    Braunschweiger PG; Kumar N; Constantinidis I; Wehrle JP; Glickson JD; Johnson CS; Furmanski P
    Cancer Res; 1990 Aug; 50(15):4709-17. PubMed ID: 2369744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors.
    Braunschweiger PG; Johnson CS; Kumar N; Ord V; Furmanski P
    Cancer Res; 1988 Nov; 48(21):6011-6. PubMed ID: 3262418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha mediates the antitumor effect of combined interleukin-2 and whole body hyperthermia.
    Fritz KL; Koziol S; Fabian DF; Lefor AT
    J Surg Res; 1996 Jan; 60(1):55-60. PubMed ID: 8592432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of photodynamic therapy and hyperthermia: tumor response and cell survival studies after treatment of mice in vivo.
    Henderson BW; Waldow SM; Potter WR; Dougherty TJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6071-7. PubMed ID: 4063964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of vascular thermotolerance on the heat-induced changes in blood flow, pO2, and cell survival in tumors.
    Lin JC; Song CW
    Cancer Res; 1993 May; 53(9):2076-80. PubMed ID: 8481910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor oxygenation after mild-temperature hyperthermia in combination with carbogen breathing: dependence on heat dose and tumor type.
    Okajima K; Griffin RJ; Iwata K; Shakil A; Song CW
    Radiat Res; 1998 Mar; 149(3):294-9. PubMed ID: 9496893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor activity of cisplatin and interleukin 1 in sensitive and resistant solid tumors.
    Braunschweiger PG; Basrur VS; Santos O; Markoe AM; Houdek PV; Schwade JG
    Cancer Res; 1993 Mar; 53(5):1091-7. PubMed ID: 8439953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the clonogenic ability of solid tumor cells during combined exposure to hyperthermia and irradiation].
    Gulverdashvili NA
    Radiobiologiia; 1987; 27(5):640-3. PubMed ID: 3671680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of IL-1 alpha and TNF-alpha potentiates the antitumour effect of hyperthermia.
    Lin JC; Park HJ; Song CW
    Int J Hyperthermia; 1996; 12(3):335-44. PubMed ID: 9044903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermoradiotherapy with hydralazine: the effect of preirradiation of the tumor bed on blood flow and growth delay of Ehrlich carcinoma.
    Kozin SV; Kozina LV
    Radiat Res; 1999 Jan; 151(1):79-84. PubMed ID: 9973088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen.
    Song CW; Shakil A; Griffin RJ; Okajima K
    Semin Oncol; 1997 Dec; 24(6):626-32. PubMed ID: 9422259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.
    Griffin RJ; Williams BW; Wild R; Cherrington JM; Park H; Song CW
    Cancer Res; 2002 Mar; 62(6):1702-6. PubMed ID: 11912143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of systemically administered bleomycin or adriamycin with local hyperthermia on primary tumor and lung metastases.
    Marmor JB; Kozak D; Hahn GM
    Cancer Treat Rep; 1979 Aug; 63(8):1279-90. PubMed ID: 89906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in intratumor pH by two heatings.
    Lin JC; Song CW
    Cancer Res; 1990 Nov; 50(22):7108-11. PubMed ID: 2224845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell kill and tumor control after heat treatment with and without vascular occlusion in RIF-1 tumors.
    Wallen CA; Colby TV; Stewart JR
    Radiat Res; 1986 May; 106(2):215-23. PubMed ID: 3704113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor responses following multiple hyperthermia and X-ray treatments: role of thermotolerance at the cellular level.
    Meyer JL; Van Kersen I; Hahn GM
    Cancer Res; 1986 Nov; 46(11):5691-5. PubMed ID: 3756917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors.
    Constantinidis I; Braunschweiger PG; Wehrle JP; Kumar N; Johnson CS; Furmanski P; Glickson JD
    Cancer Res; 1989 Nov; 49(22):6379-82. PubMed ID: 2804984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.